The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
The Trump administration has intervened in the release of important studies on the bird flu, as an outbreak escalates across the United States.